LMNB2 and prostate adenocarcinoma: In addition, we revealed that up-regulated expression levels of LMNB2 were associated with shorter PFS in ACC, bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), LGG, MESO, pancreatic adenocarcinoma (PAAD), PRAD and SARC (Figure 1C).